Robinson Welcomes COVID-19 Vaccine Collaboration Between Merck, Johnson & Johnson

New York, N.Y., March 03, 2021Peter Robinson, president and chief executive of the United States Council for International Business (USCIB), which represents many of America’s leading global companies, released a statement today in reaction to President Joe Biden’s announcement on March 2 that Merck will help make Johnson & Johnson’s single-shot COVID-19 vaccine:

“We at USCIB commend our member companies J&J and Merck for collaborating in the fight against the COVID-19 pandemic. The partnership between these two companies and the commitment of their CEOs, both of which are USCIB Trustees, brings us a great amount of pride and excitement. Over the years, our motto at USCIB has been ‘Global Business Leadership At Work’ and we are pleased that our member companies have been demonstrating that and leading by example.

“The USCIB Foundation meanwhile is also building momentum on our most recent initiative – Business Partners to CONVINCE – a global, multi-sector effort to empower a ‘vaccine-literate’ public, led by employers as trusted messengers to their employees and based on trust in science and aligned commitment to future COVID-19 vaccines and other novel countermeasures.”

Staff Contact:   Kira Yevtukhova

Deputy Director, Marketing and Communications
Tel: 202.617.3160

Kira Yevtukhova manages USCIB’s print and online publications, including the website, e-newsletter and quarterly magazine, and serves as the organization’s digital media strategist. Prior to this role, Kira worked for over five years within USCIB’s Policy Department, focusing on climate change, environment, nutrition, health, and chemicals related policy issues. She is a graduate of Mount Holyoke College and is currently pursuing an MBA at Georgetown’s McDonough School of Business.
Read More

Related Content